Hacker-City
Hacker-City
Get the brief
Business|October 13, 2026|5 min read

UnitedHealth Group tops estimates, hikes profit outlook as insurer manages high medical costs

UnitedHealth Group reported third-quarter earnings that exceeded expectations and raised its full-year profit outlook to at least $20.50 per share, as the nation's largest private insurer successfully manages elevated medical costs through value-based care and artificial intelligence investments.

#unitedhealth-group#earnings#health-insurance#medicare-advantage#value-based-care#artificial-intelligence#medical-costs#profit-outlook#q3-2026#healthcare
C

CNBC

Contributor

UnitedHealth Group tops estimates, hikes profit outlook as insurer manages high medical costs

On Tuesday, UnitedHealth Group announced third-quarter earnings that significantly surpassed forecasts while also raising its full-year profit outlook. This achievement reflects the company's ability to effectively manage elevated medical costs, primarily through investments in value-based care and advancements in artificial intelligence.

As the leading private insurer in the United States, UnitedHealth expects its fiscal 2026 adjusted earnings to reach no less than $20.50 per share, an increase from its earlier projection of $19.50 to $20 per share.

The healthcare conglomerate's revitalization strategy has gained traction following three consecutive solid quarters this year. To stabilize its profit margins, UnitedHealth has been strategically reducing its membership base, terminating unprofitable contracts, and significantly investing in artificial intelligence and value-based care. The latter model connects compensation for doctors and healthcare facilities to patient health outcomes, quality of care, and cost-effectiveness rather than the quantity of medical services delivered.

CFO Wayne DeVeydt emphasized in an interview that "you'll see in the quarter that we continue to execute not only on the financial aspects of our business, but really doing them with a simpler approach and an approach that's really focused on investing heavily in value-based care."

Third Quarter Results

The company reported the following third-quarter figures compared to Wall Street projections:

  • Earnings per share: $4.69 adjusted vs. $4.14 expected
  • Revenue: $112.69 billion vs. $111.40 billion expected

UnitedHealth posted a third-quarter net income of $4.11 billion, translating to $4.56 per share, up from $2.35 billion or $2.59 per share during the same quarter last year. Excluding certain items such as business divestitures, restructuring costs, and anticipated reductions in reserves for unprofitable contracts, the earnings per share stood at $4.69.

Despite revenue dropping to $112.69 billion from $113.16 billion in the corresponding quarter of the previous year, both UnitedHealth's insurance division, UnitedHealthcare, and its Optum healthcare unit exceeded analysts' expectations in operational earnings for the quarter.

Managing High Costs

It is noteworthy that UnitedHealth's medical cost ratio — which measures total medical expenses in relation to premiums collected — reached 88.4% for the third quarter, with analysts predicting a ratio of 89.9%. A lower ratio typically indicates the company collected more in premiums than it dispersed in benefits, leading to improved profitability.

However, DeVeydt cautioned CNBC that medical costs for the quarter "continue to be elevated versus historical norms," an ongoing challenge for insurers, particularly those engaged in the management of privately run Medicare Advantage plans, for over two years.

"I think it's something we should keep an eye on. I think you'll see that our medical care ratio has improved quite a bit, but I don't want that to be misleading in terms of [medical cost trends]," DeVeydt noted.

He pointed out that the independent dispute resolution (IDR) process under the No Surprises Act is adding at least 100 basis points, or 1 percentage point, to total medical expenses. This federal law, which became effective in 2022, aims to shield consumers from unexpected medical bills.

The IDR process facilitates the resolution of disputes regarding out-of-network payments between providers and insurers. DeVeydt elaborated that these regulatory changes are elevating the company's claims costs, which may ultimately lead to increased premiums for consumers.

He also noted that costs associated with inpatient services and pharmaceuticals, especially expensive specialty drugs for cancer and rare diseases, remain high.

Despite these challenges, he underscored the positive impact of the company's value-based care initiatives, which are instrumental in managing medical costs by directing patients toward appropriate providers and emphasizing preventive care.

Year-over-year, acute hospital admissions among UnitedHealth members have decreased by 15% through the third quarter, while home health admissions rose by 10%, indicating a trend where more patients are receiving care in lower-cost settings.

"You're finding more members are actually getting into a lower-cost care environment, but more importantly, they're getting into the care environment they actually want to be in," he remarked to CNBC. "So we think we're really balancing both the quality and the cost."

Technology and Innovation

UnitedHealth is also implementing AI-driven ambient listening technologies designed to alleviate administrative burdens on physicians and enable them to dedicate more time to patient interactions. Reportedly, the percentage of appointment scheduling completed by patients independently — without provider assistance — increased by 27% year over year, as stated by DeVeydt.

He anticipates that these initiatives will have a cumulative effect on managing medical costs throughout the fourth quarter and into 2027 as they scale up.

Share this story